Paysign Inc is a financial technology company that specializes in providing prepaid card solutions and payment processing services, primarily for the healthcare and other industries. The company focuses on delivering innovative payment solutions that streamline transactions for patients, providers, and businesses. By leveraging its advanced technology platform, Paysign facilitates secure and efficient financial transactions, enabling organizations to enhance their payment workflows and improve customer experiences. With a commitment to compliance and risk management, Paysign serves a diverse clientele by offering customized card programs and payment solutions tailored to specific industry needs. Read More
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be presenting at the 17th Annual Southwest IDEAS Investor Conference to be held Wednesday and Thursday, November 19 and 20, 2025, in Dallas, Texas.
Paysign Q3 2025 earnings crush estimates with 41.6% revenue growth. Its high-margin pharma business soared 141.9%, driving strong profitability and a raised 2025 outlook.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, today announced financial results for the third quarter 2025.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, will discuss third quarter 2025 earnings at 5:00 p.m. Eastern time on Wednesday, November 12, 2025.
Could Paysign (PAYS) be the next big investment opportunity? Join our experts as they break down its strengths, risks, and potential for growth in the competitive payment industry.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management software platforms and integrated payment processing for the life sciences industries, today announced that it has appointed Jose Garcia as Executive Vice President, Life Science Solutions.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today posted the following summary notice of pendency and proposed settlement of stockholder derivative actions.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced the opening of a new 30,000 square foot patient service support center in Henderson, Nevada. The facility increases Paysign’s support capacity fourfold and will bolster the company’s rapidly growing patient affordability business.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced they will be attending the ninth annual Lake Street Best Ideas Growth BIG9 Conference to be held Thursday, September 11, 2025.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability programs, donor compensation solutions, engagement and management platforms and integrated payment processing for the life sciences industries, today announced that its board of directors has elected Dan Henry as Chairman of the Board, succeeding Mark Newcomer who will continue in his role as President and Chief Executive Officer.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive pharma patient affordability offerings, financial technology products and integrated payment processing, today announced they will be presenting at the Oppenheimer 28th Annual Technology, Internet & Communications Conference to be held August 11-13, 2025, through a virtual format.
Stay up-to-date with the latest market trends in the middle of the day on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive pharma patient affordability offerings, financial technology products and integrated payment processing, today announced financial results for the second quarter 2025.
PaySign Inc (PAYS) aligns with Mark Minervini’s Trend Model, showing strong technicals, high relative strength, and robust earnings growth, making it a high-momentum stock to watch.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of prepaid card programs, comprehensive patient affordability offerings, financial technology products and integrated payment processing, will discuss second quarter 2025 earnings at 5:00 p.m. Eastern time on Tuesday, August 5, 2025.
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced the successful transition of 123 out of 132 newly awarded plasma donation centers. The remaining nine centers are on track to go live in the third quarter of 2025.
